Does lung function change in the months after an asthma exacerbation in children? Source: Virtual Congress 2021 – Paediatric asthma and bronchopulmonary dysplasia Year: 2021
Six months azithromycin treatment in COPD patients with high risk of further exacerbations Source: International Congress 2017 – Management of COPD Year: 2017
The course of disease of patients who died from asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003
The effect of 3 months oral clarithromycin on sputum bacterial colonization in stable moderate- to- severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001
Five years follow-up after pulmonary rehabilitation of patients with COPD Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010
Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008
The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Assessments of respiratory function in early lung disease in infants and young children with CF Source: Annual Congress 2012 - Cournand Lecture followed by Hot Topic "Early intervention in CF: why, when and how?" Year: 2012
Azithromycin in the treatment of children with chronic inflammatory lung disease (CILD) Source: Eur Respir J 2004; 24: Suppl. 48, 391s Year: 2004
Azithromycin in the treatment of children with chronic airway disease (CAD) Source: Eur Respir J 2003; 22: Suppl. 45, 143s Year: 2003
The effect of pulmonary rehabilitation in 75 years and older patients with COPD Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010
CF disease progress regarding lung symptoms – a cohort study Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018
Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011
Does regular physiotherapy prevent LRTIs in patients with chronic lung disease? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009
Effects of the home-realized 6 months follow-up study individually designed exercise programme on patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 556s Year: 2006
Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021 Year: 2022
Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease? Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019